4553
Fiscal year ends March Quarters are offset from the calendar — Q1 is Apr–Jun

Towa Pharmaceutical Co., Ltd. is a pharmaceutical company that manufactures and sells generic medicines. The company operates through two main segments: domestic and overseas. In the domestic segment, it sells products directly to medical institutions and through agents, wholesalers, and other manufacturers. Key subsidiaries include Jaidolph Pharmaceutical, which handles product trading and contract manufacturing; Daichi Chemical, which conducts research and manufacturing of active pharmaceutical ingredients; Green Caps Pharmaceutical, which manufactures soft capsules; and Sanshoku Pharmaceutical, which engages in the planning, development, and contract manufacturing of health foods and pharmaceuticals. In the overseas segment, Towa Pharma International Holdings, S.L. serves as a holding company for generic pharmaceutical operations in Europe and the Americas, with group companies providing research, development, manufacturing, and sales services.

Summarised from the annual report, fiscal year ended Mar 2026

Industry Drug Manufacturers - Specialty & Generic Homepage towayakuhin.co.jp
Sector Healthcare IR page towayakuhin.co.jp
Tags
generic medicines, contract manufacturing, active pharmaceutical ingredients, soft capsules, health foods, pharmaceutical research, medical institutions, Jaidolph Pharmaceutical, Daichi Chemical, Green Caps Pharmaceutical, Sanshoku Pharmaceutical, Towa Pharma International Holdings S.L.
Press page towayakuhin.co.jp/company/press

Metrics

Valuation  
Market cap ¥ 185.236B
Market cap (USD) $ 1.158B
P/E 46.23
PEG 1.38
P/BV 0.97
P/S 0.65
P/OCF 6.94
P/FCF 20.47
Dividend yield 2.2%
Turnover / mcap —
Returns  
ROE 3.0%
ROI 1.4%
ROIC 3.1%
Profit margin 1.9%
Growth  
Revenue growing Yes
Profits growing No
Revenue up 3y Yes
Revenue up 5y Yes
Earnings growth 3y (net profit CAGR) 33.6%
Quality  
Profitable Yes
Margin expanding No
Buying back stock No
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 44
Quality score -11.1%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Revenue 273.71B 259.594B 227.934B 208.859B 165.615B 154.9B 110.384B 105.104B 93.43B 84.949B 82.115B 71.47B 61.351B 55.241B
Net profit 5.25B 18.986B 16.173B 2.201B 15.914B 13.958B 14.503B 13.475B 6.495B 5.576B 7.684B 11.118B 5.992B 6.201B
Free cash flow 6.301B -7.822B -29.639B -27.925B 8.553B 2.129B 14.494B 7.859B 3.857B -10.973B -10.385B — — —

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Share price 4.005K 2.68K 2.904K 1.895K 2.749K 2.443K 2.266K 2.913K 6.65K 5.63K 4.615K 6.871K 4.455K 4.99K
Price performance 12m 0.49 -0.08 0.53 -0.31 0.13 0.08 -0.22 -0.56 0.18 0.22 -0.33 0.54 -0.11 —

Filed figures

Figure Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Balance sheet detail
Trade receivables (JPY) 26.2B 30.5B 34.6B 41.6B 45.8B 93.8B 101B 135B 133B 137B
↳ YoY growth +1.6% +16.2% +13.7% +20.1% +10.2% +104.7% +8.1% +32.9% -1.0% +3.1%
↳ 5y CAGR +12.2% +29.0% +27.2% +31.2% +26.2% +24.6%
Borrowings, current (JPY) 4.42B 5.1B 7.25B 28.1B 8.29B 57.4B 11.2B 13.2B 22.7B 28.9B
Borrowings, non-current (JPY) 39.3B 44.8B 43.4B 36.6B 69.9B 79.2B 150B 189B 195B 183B
Lease liabilities (JPY) — — — — — — — 952M 13.2B 14.5B
Cash and deposits (JPY) 9.44B 14.2B 26.8B 18.7B 22.9B 32.8B 24.3B 29.7B 45.5B 45.3B
Intangible assets (JPY) 1.89B 1.94B 1.47B 17.7B 15B 54.1B 52.9B 50.6B 45.8B 26.7B
Net debt (borrowings + leases - cash) (JPY) 34.2B 35.7B 23.9B 46.1B 55.3B 104B 137B 173B 186B 181B
Cash flow detail
Operating cash flow (JPY) 10.2B 19.2B 19B 19.2B 12B 22.1B 2.54B 8.21B 23.4B 30.4B
Purchases of property, plant and equipment (JPY) -20.5B -14.5B -11.1B -4.55B -9.14B -11.1B -28.7B -37.9B -28.7B -22.3B
Purchases of intangible assets (JPY) -680M -897M -211M -121M -742M -2.44B -1.74B -1.47B -2.49B -1.85B
Change in receivables (cash effect) (JPY) -421M -4.24B -4.15B 2.78B -4.54B 441M -1.59B -15.5B -565M -792M
Change in inventories (cash effect) (JPY) -2.44B 3.19B -1.62B -4.3B -9.71B -7.95B -18.5B -6.29B -7.2B -13.8B
Change in payables (cash effect) (JPY) -1.37B -967M 4.66B 1.83B 2.45B 3.68B 6.55B -10.5B 3.69B 2.95B
Dividends paid (cash effect) (JPY) -1.56B -1.56B -1.56B -2.07B -2.17B -2.41B -3.1B -2.95B -2.95B -3.94B
Share buybacks (cash effect) (JPY) 0.00 — 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest paid (cash effect) (JPY) -163M -161M -148M -130M -172M -226M -610M -941M -1.59B -2.23B
Income taxes paid (cash effect) (JPY) -1.26B -1.5B -4.23B -6.87B -6.75B -5.01B -6.29B -1.76B -10.9B -8.52B
Operating cash flow before change in receivables (JPY) 10.6B 23.5B 23.2B 16.4B 16.6B 21.7B 4.14B 23.7B 24B 31.2B
Free cash flow (OCF - PPE - intangibles) (JPY) -11B 3.86B 7.65B 14.5B 2.13B 8.55B -27.9B -31.1B -7.82B 6.3B
Income detail
Research and development expense (JPY) 9.35B 7.73B 7.92B 8.57B 10.6B 11.5B 15.3B 13.2B 16.2B 17.9B
↳ 5y CAGR +3.6% +4.2% +14.6% +10.8% +13.6% +11.0%
Total comprehensive income (JPY) 5.86B 6.53B 13.4B 14.9B 14.5B 18B 7.83B 21.9B 18.6B 10.4B
Comprehensive income to owners (JPY) 5.86B 6.53B 13.4B 14.9B 14.5B 18B 7.83B 21.9B 18.6B 10.4B
Provision for credit losses (JPY) 3M 365M 0.00 5M 43M 781M 109M 88M 320M 11M
Credit cost ratio (credit losses / average receivables) (%) 0.0% 1.3% 0.0% 0.0% 0.1% 1.1% 0.1% 0.1% 0.2% 0.0%
Reported Jun 28, 2017 Jun 27, 2018 Jun 26, 2019 Jun 25, 2020 Jun 28, 2021 Jun 27, 2022 Jun 28, 2023 Nov 13, 2024 Jun 24, 2025 Jun 22, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Prompts

Towa Pharmaceutical Co., Ltd. (ticker 4553), listed in Japan.

ETFs Holding Towa Pharmaceutical Co., Ltd.

ETF Weight in ETF Shares Market value As of
DISV 0.07% 165,100 $ 3.49M Nov 12, 2026
AVDV 0.02% 211,500 $ 4.535M Nov 16, 2026
AVDS 0.02% 3,500 $ 75.047K Nov 16, 2026
DXIV 0.02% 1,900 $ 40.163K Nov 12, 2026
DFIS 0.01% 35,500 $ 750.407K Nov 12, 2026
AVDE 0.01% 46,000 $ 986.331K Nov 16, 2026
DFIC 0.01% 41,900 $ 885.691K Nov 12, 2026
DFAX 0.00% 24,600 $ 520K Nov 12, 2026
DFAI 0.00% 21,800 $ 460.813K Nov 12, 2026
DFSI 0.00% 1,200 $ 25.366K Nov 12, 2026